Literature DB >> 33278661

Can the radiological scale "iNPH Radscale" predict tap test response in idiopathic normal pressure hydrocephalus?

Tiberiu Laticevschi1, Alma Lingenberg2, Stéphane Armand3, Alessandra Griffa2, Frédéric Assal4, Gilles Allali5.   

Abstract

BACKGROUND: Idiopathic normal pressure hydrocephalus (iNPH) presents typical radiological signs that have been summarised in a semi-quantitative scale named the iNPH Radscale. However, the iNPH Radscale's predictive value for response to cerebrospinal fluid (CSF) tap test has never been studied. This study aims to investigate if the iNPH Radscale can predict locomotion improvement after CSF tap test.
METHODS: A total of 100 patients with iNPH (age: 76.3 ± 7.9, gender: 36% female) were included in this retrospective study. Two raters, blinded to the response of the CSF tap test, evaluated the iNPH Radscale and its seven subitems (Evan's index, callosal angle, size of temporal horns, narrow high-convexity sulci, dilated Sylvian fissures, focally dilated sulci, and periventricular hypodensities). Locomotion improvement was assessed by the Timed Up and Go (TUG) performed before, and 24 h after, the CSF tap test.
RESULTS: The iNPH Radscale (total score) was similar between the CSF tap test responders and non-responders (responders: 8.31 ± 1.96, non-responders: 9.18 ± 2.51, p = 0.128). However, the temporal horns score was smaller in the responders group (1.66 ± 0.57 versus 1.94 ± 0.24, p = 0.045), even after adjusting for age, gender, education level, white matter changes, and global cognition (β: -0.250, C.I. 95%: [-3.185; -0.161], p = 0.031).
CONCLUSION: The iNPH Radscale (total score) does not predict locomotion improvement after CSF tap test, while a smaller temporal horns score at baseline is associated with a positive tap test responder status.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gait; Imaging; Normal pressure hydrocephalus; TUG; Tap test

Mesh:

Year:  2020        PMID: 33278661     DOI: 10.1016/j.jns.2020.117239

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Value of MRI-based semi-quantitative structural neuroimaging in predicting the prognosis of patients with idiopathic normal pressure hydrocephalus after shunt surgery.

Authors:  Jiakuan Chen; Wenjie He; Xiejun Zhang; Minrui Lv; Xi Zhou; Xiaolin Yang; Haihua Wei; Haiqin Ma; Hongbing Li; Jun Xia
Journal:  Eur Radiol       Date:  2022-04-30       Impact factor: 5.315

2.  Can Shunt Response in Patients with Idiopathic Normal Pressure Hydrocephalus Be Predicted from Preoperative Brain Imaging? A Retrospective Study of the Diagnostic Use of the Normal Pressure Hydrocephalus Radscale in 119 Patients.

Authors:  J F Carlsen; A D L Backlund; C A Mardal; S Taudorf; A V Holst; T N Munch; A E Hansen; S G Hasselbalch
Journal:  AJNR Am J Neuroradiol       Date:  2021-12-30       Impact factor: 3.825

3.  Callosal Angle Sub-Score of the Radscale in Patients with Idiopathic Normal Pressure Hydrocephalus Is Associated with Positive Tap Test Response.

Authors:  Efstratios-Stylianos Pyrgelis; George P Paraskevas; Vasilios C Constantinides; Fotini Boufidou; Georgios Velonakis; Leonidas Stefanis; Elisabeth Kapaki
Journal:  J Clin Med       Date:  2022-05-20       Impact factor: 4.964

4.  CSF tap test in idiopathic normal pressure hydrocephalus: still a necessary prognostic test?

Authors:  Alessandra Griffa; Giulia Bommarito; Frédéric Assal; Maria Giulia Preti; Rachel Goldstein; Stéphane Armand; François R Herrmann; Dimitri Van De Ville; Gilles Allali
Journal:  J Neurol       Date:  2022-05-22       Impact factor: 6.682

Review 5.  Clinical predictors of shunt response in the diagnosis and treatment of idiopathic normal pressure hydrocephalus: a systematic review and meta-analysis.

Authors:  Santhosh G Thavarajasingam; Mahmoud El-Khatib; Mark Rea; Salvatore Russo; Johannes Lemcke; Lana Al-Nusair; Peter Vajkoczy
Journal:  Acta Neurochir (Wien)       Date:  2021-07-08       Impact factor: 2.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.